SARS-CoV-specific B-cell epitope and applications thereof
AssigneeNational Taiwan University
InventorsHan-Chung Wu, I-Ju Liu, Chien-Yu Chiu
Life of this patent
Estimating the term…
Abstract
Disclosed is SARS-CoV-specific B-cell epitope and applications thereof. The epitopes are peptides and can either be expressed in phages or synthesized to diagnose SARS patients accurately. High sensitivity and specificity of the serologic detection are achievable by using a plurality of SARS-CoV-specific B-cell epitope-based peptides. Therefore, the peptides can be applied to SARS diagnosis and have potentials to be immunogens for producing antibodies against SARS.
Claims7
A SARS-CoV-specific B-cell epitope for diagnosing SARS patients, having at least one amino acid sequence selected from the group consisting of SEQ ID NO:
- 13, SEQ ID NO:
- 14 and SEQ ID NO:
- 15.
A SARS-CoV-specific B-cell epitope-based peptide for diagnosing SARS patients, having at least one amino acid sequence selected from the group consisting of SEQ ID NO:
- 13, SEQ ID NO:
- 14 and SEQ ID NO:
- 15.
An immunogen having at least one SARS-CoV-specific B-cell epitope for producing antibodies, wherein the epitope is selected from the group consisting of SEQ ID NO:
- 13, SEQ ID NO:
- 14 and SEQ ID NO:
- 15.
An immunogen having at least one SARS-CoV-specific B-cell epitope-based peptide for producing antibodies, wherein the peptide is selected from the group consisting of SEQ ID NO:
- 13, SEQ ID NO:
- 14 and SEQ ID NO:
- 15.
Dependencies are inferred from the claim text.